Viral vectors are vital for the cell and gene therapy industry. However, long production timelines, combined with quality and consistency issues, mean that growing demand is outstripping supply.

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...

Topics Bioprocessing Insights Digital Twin Focuses on Improving Viral Vector Production By Vivienne Raper, PhD April 2, 2025 ...

A team of researchers from the Spanish National Research Council has made a significant advance in plant biotechnology by ...

HOPEWELL, N.J., June 25, 2024 /PRNewswire/ -- ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral ...

Title: An Extended Kinetic Study of AAV Viral Vector Production Presenters: Daniel Brownell and Lucia Fernandez, PhD Session Date/Time: May 15, 2025, 5:30 PM - 7:00 PM ...

Viral vector service expansion empowers scientists by offering high-quality research reagents through on-demand AAV production from Addgene’s vast plasmid repository Addgene, a purpose-driven ...

CDMO ProBio, the biologics subsidiary of GenScript, expanded its plasmid DNA and viral vector production capacity with the opening of new manufacturing facility in Hopewell, New Jersey. The site ...

Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...

ProBio's new state-of-the-art facility in Hopewell, New Jersey, set to become the hub for North American operations, enhancing the production of transformative plasmid DNA and viral vector-based ...